SYSTEMATIC REVIEW OF THE COST-EFFECTIVENESS OF ABEMACICLIB IN THE TREATMENT OF HR+/HER2− ADVANCED OR METASTATIC BREAST CANCER . (2026). Vietnam Journal of Community Medicine, 67(10). https://doi.org/10.52163/yhc.v67i10.6967